TY - JOUR
T1 - Backbone cyclization of the C-terminal part of substance P. Part 1
T2 - The important role of the sulphur in position 11
AU - Bitan, Gal
AU - Zeltser, Irena
AU - Byk, Gerardo
AU - Halle, David
AU - Mashriki, Yaffa
AU - Gluhov, Evgenia V.
AU - Sukhotinsky, Inna
AU - Hanani, Menachem
AU - Selinger, Zvi
AU - Gilon, Chaim
PY - 1996
Y1 - 1996
N2 - Novel backbone-to-side chain and backbone-to-backbone cyclic analogues of substance P (SP) were prepared by solid-phase synthesis and screened for biological activity. An analogue containing a thioetherlactam ring between positions 9 and 11 showed an EC50 value of 20 nM toward the neurokinin 1 (NK-1) and was inactive toward the NK-2 and NK-3 receptors. On the other hand, in a multiple backbone cyclic peptide library of similar analogues, in which the sulphur was excluded from the ring, very low activity was detected. The activity was re-evaluated and was found to be even lower (EC50 = 0.11 mM) than the previously published data. These results indicate that the thioether moiety has a crucial role in receptor activation. The results also show tolerance of the NK-1 receptor, but not NK-2 or NK-3, to cyclization of the C-terminal portion of the SP6-11 hexapeptide.
AB - Novel backbone-to-side chain and backbone-to-backbone cyclic analogues of substance P (SP) were prepared by solid-phase synthesis and screened for biological activity. An analogue containing a thioetherlactam ring between positions 9 and 11 showed an EC50 value of 20 nM toward the neurokinin 1 (NK-1) and was inactive toward the NK-2 and NK-3 receptors. On the other hand, in a multiple backbone cyclic peptide library of similar analogues, in which the sulphur was excluded from the ring, very low activity was detected. The activity was re-evaluated and was found to be even lower (EC50 = 0.11 mM) than the previously published data. These results indicate that the thioether moiety has a crucial role in receptor activation. The results also show tolerance of the NK-1 receptor, but not NK-2 or NK-3, to cyclization of the C-terminal portion of the SP6-11 hexapeptide.
KW - Agonist
KW - Backbone cyclization
KW - Conformational constraint
KW - Substance P
UR - http://www.scopus.com/inward/record.url?scp=0030178429&partnerID=8YFLogxK
U2 - 10.1002/(SICI)1099-1387(199607)2:4<261::AID-PSC76>3.0.CO;2-T
DO - 10.1002/(SICI)1099-1387(199607)2:4<261::AID-PSC76>3.0.CO;2-T
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 9231334
AN - SCOPUS:0030178429
SN - 1075-2617
VL - 2
SP - 261
EP - 269
JO - Journal of Peptide Science
JF - Journal of Peptide Science
IS - 4
ER -